title: Surface functionalized amorphous nanosilica and microsilica with nanopores as promising tools in biomedicine.
abstract: Cellular interactions with engineered nanoparticles (NPs) are dependent on many properties, inherent to the nanoparticle (viz. size, shape, surface characteristics, degradation, agglomeration/dispersal, and charge, etc.). Modification of the surface reactivity via surface functionalization of the nanoparticles to be targeted seems to be important. Utilization of different surface functionalization methods of nanoparticles is an emerging field of basic and applied nanotechnology. It is well known that many disease-causing organisms induce host lipids and if deprived, their growth is inhibited in vivo. Amorphous nanosilica (ANS) and amorphous microsilica with nanopores (AMS) were prepared by a combination of wet chemistry and high-energy ball milling. Lipophilic moieties were attached to both ANS and AMS via chemical surface functionalization method. Lipophilic ANS and AMS were found to inhibit the growth of Bombyx mori nuclear polyhedrosis virus (BmNPV) and chicken malarial parasites via absorption of silkworm hemolymph and chicken serum lipids/lipoproteins, respectively, in vivo. Therefore, intelligent surface functionalization of NP is an important concept, and its application in curing chicken malaria and BmNPV is presented here. Surface functionalization method reported in this paper might serve as a valuable technology for treating many diseases where pathogens induce host lipid.
authors.affiliation: Biological Sciences Division, Indian Statistical Institute, 203 B. T. Road, Calcutta, India. ayesha.rahman.l@gmail.com
authors.forename: Ayesha
authors.initials: A
authors.lastname: Rahman
authors.forename: Dipankar
authors.initials: D
authors.lastname: Seth
authors.forename: Sunit K
authors.initials: SK
authors.lastname: Mukhopadhyaya
authors.forename: Ratan L
authors.initials: RL
authors.lastname: Brahmachary
authors.forename: Christian
authors.initials: C
authors.lastname: Ulrichs
authors.forename: Arunava
authors.initials: A
authors.lastname: Goswami
mesh_terms: D000818:Animals; D020811:Biomedical Technology / Q000379:methods*; D012831:Bombyx / Q000187:drug effects / Q000254:growth & development / Q000502:physiology; D002645:Chickens; D002784:Cholesterol / Q000097:blood; D004195:Disease Models, Animal; D007814:Larva / Q000502:physiology; D008288:Malaria / Q000097:blood / Q000473:pathology; D055616:Microtechnology / Q000379:methods; D053758:Nanoparticles / Q000627:therapeutic use; D036103:Nanotechnology / Q000379:methods; D009929:Organ Size; D012822:Silicon Dioxide / Q000737:chemistry*; D013499:Surface Properties
chemical_list: D012822:Silicon Dioxide; D002784:Cholesterol
references.citation: Eur J Med Res. 1998 Apr 8;3(4):211-5
references.pmid: 9533930
references.citation: J Biol Chem. 2001 Aug 3;276(31):29319-29
references.pmid: 11352913
references.citation: Commun Agric Appl Biol Sci. 2006;71(2 Pt A):171-8
references.pmid: 17390789
references.citation: Bull Hist Med. 2005 Summer;79(2):261-94
references.pmid: 15965289
references.citation: Nat Immunol. 2005 Sep;6(9):946-53
references.pmid: 16086017
references.citation: J Stored Prod Res. 2001 Apr;37(2):153-164
references.pmid: 11124378
references.citation: J Biol Chem. 1994 Dec 30;269(52):33159-63
references.pmid: 7806546
references.citation: Nat Rev Immunol. 2003 Jul;3(7):557-68
references.pmid: 12876558
references.citation: Lipids Health Dis. 2005 May 09;4:10
references.pmid: 15882457
references.citation: EMBO J. 2000 Jul 17;19(14):3556-64
references.pmid: 10899110
references.citation: Naturwissenschaften. 2007 Jan;94(1):25-33
references.pmid: 16953417
references.citation: Expert Rev Anticancer Ther. 2007 Jun;7(6):833-7
references.pmid: 17555393
references.citation: Mini Rev Med Chem. 2008 Feb;8(2):175-83
references.pmid: 18289101
references.citation: Expert Opin Drug Deliv. 2007 Mar;4(2):119-29
references.pmid: 17335410
references.citation: Insect Biochem Mol Biol. 1998 Dec;28(12):927-34
references.pmid: 9887509
references.citation: Biosci Biotechnol Biochem. 2007 Jan;71(1):200-5
references.pmid: 17213661
references.citation: Curr Opin Immunol. 1995 Feb;7(1):4-10
references.pmid: 7772280
references.citation: Immunol Lett. 1998 Jun;62(2):59-66
references.pmid: 9698099
references.citation: Langmuir. 2007 Feb 13;23(4):2158-68
references.pmid: 17279708
references.citation: Nature. 2007 Dec 13;450(7172):1091-5
references.pmid: 18046333
references.citation: Parasitol Res. 2002 Dec;88(12):1040-3
references.pmid: 12444452
references.citation: Trans R Soc Trop Med Hyg. 1990 Nov-Dec;84(6):792-4
references.pmid: 2096509
references.citation: Nat Protoc. 2008;3(2):314-20
references.pmid: 18274533
references.citation: Indian J Cancer. 2004 Jan-Mar;41(1):47
references.pmid: 15105580